Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients-Reference-Cited by-同舟云学术

Guideline for primary antifungal prophylaxis for pediatric patients with cancer or hematopoietic stem cell transplant recipients

Published:2013-11-26 Issue:3 Volume:61 Page:393-400
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Science Michelle¹²,Robinson Paula D.³⁴,MacDonald Tamara⁵,Rassekh Shahrad Rod⁶,Dupuis L. Lee⁷⁸⁹,Sung Lillian⁸⁹

Affiliation:

1. Division of Infectious Diseases; The Hospital for Sick Children; Toronto Ontario

2. Department of Clinical Epidemiology and Biostatistics; McMaster University; Hamilton Health Sciences; Hamilton Ontario

3. C17 Council; 3-590B Edmonton Clinic Health Academy (ECHA); Department of Pediatrics; University of Alberta; Edmonton AB

4. Pediatric Oncology Group of Ontario; Toronto Ontario

5. Department of Pharmacy; IWK Health Centrem; Dalhousie University; Halifax Nova Scotia

6. Division of Pediatric Hematology/Oncology/BMT; BC Children's Hospital; Vancouver British Columbia

7. Department of Pharmacy; The Hospital for Sick Children, Leslie Dan Faculty of Pharmacy, University of Toronto; Toronto Ontario

8. Division of Haematology/Oncology; The Hospital for Sick Children; Toronto Ontario

9. Program in Child Health Evaluative Sciences; The Hospital for Sick Children; Toronto Ontario

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pbc.24847/fullpdf

Reference71 articles.

1. Aspergillosis case-fatality rate: Systematic review of the literature;Lin;Clin Infect Dis,2001

2. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective;Tomblyn;Biol Blood Marrow Transplant,2009

3. Antifungal prophylaxis in adult stem cell transplantation and haematological malignancy;Slavin;Intern Med J,2008

4. Primary prophylaxis of invasive fungal infections in patients with hematologic malignancies. Recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology;Cornely;Haematologica,2009

5. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients;CDC, IDSA, and ASBMT;Biol Blood Marrow Transplant,2000

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred Therapy for Specific Fungal Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-14

2. Assessment of micafungin dosage regimens against Candida spp. in pediatric patients undergoing hematopoietic stem cell transplantation: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation;Journal of Chemotherapy;2023-05-15

3. Preferred Therapy for Specific Fungal Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

4. Invasive fungal infections in hematologic malignancies: Incidence, management, and antifungal therapy;J RES MED SCI;2023

5. Enzymatic and antifungal susceptibility profiles of Candida glabrata isolates from paediatric patients and their genetic diversity based on microsatellite length polymorphism;Letters in Applied Microbiology;2022-12-01